Concord Medical Services Holding Limited (CCM) Stock Price

CCMStock

$4.76−14.08%52W

Market Cap$20.67M

P/E—

PEG Ratio0.56

Div yield—

Beta-0.90

CCM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)26.85%

Price vs S&P 500 (4W)4.24%

PEG Ratio0.56

VGM Score62.60

Book Value / Share (Quarterly)$-0.90

P/TBV (Annual)2.10x

Revenue Growth (3Y)27.34%

Price vs S&P 500 (YTD)10.70%

Gross Margin (TTM)11.58%

Net Profit Margin (TTM)-25.27%

EPS (TTM)$-0.11

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-0.11

Revenue Growth (5Y)19.26%

EPS (Annual)$-0.11

ROI (Annual)-17.08%

Gross Margin (Annual)5.61%

Net Profit Margin (5Y Avg)-94.70%

Cash / Share (Quarterly)$0.20

Revenue Growth QoQ (YoY)97.22%

ROA (Last FY)-1.42%

Revenue Growth TTM (YoY)40.12%

EBITD / Share (TTM)$-0.21

ROE (5Y Avg)-21.09%

Operating Margin (TTM)-44.96%

Cash Flow / Share (Annual)$-0.64

Net Income / Employee (Annual)$-23,160

EV / Revenue (TTM)12.67x

Net Interest Coverage (TTM)-2.58x

ROA (TTM)-1.40%

EPS Incl Extra (Annual)$-0.11

Current Ratio (Annual)0.48x

Quick Ratio (Quarterly)0.18x

3-Month Avg Trading Volume0.07M

52-Week Price Return-14.08%

Revenue / Employee (TTM)$64,848

Tangible BV / Share (Quarterly)$-1.34

P/S Ratio (Annual)0.31x

Asset Turnover (Annual)0.07x

52-Week High$1.04

Operating Margin (5Y Avg)-128.84%

EPS Excl Extra (Annual)$-0.11

CapEx CAGR (5Y)-20.39%

Tangible BV CAGR (5Y)-23.24%

26-Week Price Return38.78%

Quick Ratio (Annual)0.21x

13-Week Price Return-2.86%

Total Debt / Equity (Annual)2.14x

Current Ratio (Quarterly)0.48x

Enterprise Value$488.73M

Revenue / Share Growth (5Y)19.08%

Asset Turnover (TTM)0.04x

Book Value / Share Growth (5Y)-26.58%

Revenue / Employee (Annual)$114,909

Inventory Turnover (Annual)10.95x

Pretax Margin (Annual)-81.07%

Cash / Share (Annual)$0.40

3-Month Return Std Dev90.42%

Gross Margin (5Y Avg)-8.10%

Net Income / Employee (TTM)$-23,160

ROE (Last FY)-53.70%

Net Interest Coverage (Annual)-2.58x

EPS Basic Excl Extra (Annual)$-0.11

P/FCF (TTM)0.26x

Receivables Turnover (TTM)6.53x

EPS Incl Extra (TTM)$-0.11

Receivables Turnover (Annual)3.92x

ROI (TTM)-63.60%

P/S Ratio (TTM)0.55x

Pretax Margin (5Y Avg)-152.63%

Revenue / Share (Annual)$0.52

Tangible BV / Share (Annual)$0.55

Price vs S&P 500 (52W)-32.64%

Year-to-Date Return23.32%

5-Day Price Return-4.42%

EPS Normalized (Annual)$-0.11

ROA (5Y Avg)-4.69%

Net Profit Margin (Annual)-20.15%

Month-to-Date Return7.57%

Cash Flow / Share (TTM)$-0.07

EBITD / Share (Annual)$-0.18

Operating Margin (Annual)-56.78%

LT Debt / Equity (Annual)1.14x

ROI (5Y Avg)-7.87%

EPS Basic Excl Extra (TTM)$-0.11

P/B Ratio (Annual)2.51x

Inventory Turnover (TTM)10.95x

Pretax Margin (TTM)-72.25%

Book Value / Share (Annual)$0.50

Price vs S&P 500 (13W)-4.81%

Beta-0.90x

P/FCF (Annual)0.33x

Revenue / Share (TTM)$0.29

ROE (TTM)-11.58%

52-Week Low$0.47

vGradeB

gGradeA

mGradeD

vgmGradeB

CCM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2019	Aug 23, 2019	-$0.04	-$0.64	-1548.12%(-$0.60)

CCM Analyst Recommendations

Sep 2021

Oct 2021

Nov 2021

Dec 2021

2.13

Industry Peers — Physicians' Offices(12)

Symbol	Value Score	Growth Score	Momentum Score	Price
CCMConcord Medical Services Holding Limited	B	A	D	$4.76
HIMSHims & Hers Health, Inc.	D	C	C	$28.84
TDOCTeladoc Health, Inc.	A	C	C	$6.50
STLNStarling Oncology, Inc. Common Stock	—	—	B	$6.17
TOIThe Oncology Institute, Inc. Common Stock	D	A	A	$5.13
SBCSBC Medical Group Holdings Incorporated Common Stock	B	F	C	$4.05
AUNAAuna S.A.	A	D	C	$5.18
AIRSAirSculpt Technologies, Inc. Common Stock	D	D	D	$2.60
LFMDLifeMD, Inc. Common Stock	C	C	D	$3.14
BMGLBasel Medical Group Ltd Ordinary Shares	A	A	F	$5.24
SBCWWSBC Medical Group Holdings Incorporated Warrants	—	—	A	$0.32
STLNWStarling Oncology, Inc. Warrant	—	—	A	$0.07
TOIIWThe Oncology Institute, Inc. Warrant	—	—	B	$0.05

About Concord Medical Services Holding Limited

Concord Medical Services Holdings Ltd operates radiotherapy, diagnostic imaging, and cancer treatment centers throughout China. The company provides premium cancer and proton therapy services while also generating revenue through medical equipment leasing and hospital management services.